Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole
NCT00237224
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Letrozole
Sponsor
Novartis Pharmaceuticals